Holista Colltech Limited (ASX:HCT)

Market Cap	23.17M +350.5%
Revenue (ttm)	5.76M +3.0%
Net Income	-948.92K
EPS	-0.00
Shares Out	367.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,296
Average Volume	31,885
Open	0.0630
Previous Close	0.0630
Day's Range	0.0630 - 0.0630
52-Week Range	0.0300 - 0.1100
Beta	1.27
RSI	30.54
Earnings Date	May 29, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2025, Holista Colltech's revenue was 5.76 million, an increase of 2.96% compared to the previous year's 5.60 million. Losses were -948,921, 1026.8% more than in 2024.